-
Lululemon Analysts Bullish After Q3 Print Amid High Expectations
Thursday, December 12, 2019 - 12:21pm | 918Lululemon Athletica Inc (NASDAQ: LULU) shares are trading down sharply despite the retailer's third-quarter earnings and sales beat on Wednesday. Here's what Wall Street analysts have to say. Piper Jaffray: Lululemon Loyalty Program Shows Promise Analyst Erinn Murphy...
-
'Nike Continues To Expand The Market': Analysts Applaud Q1 Beat
Wednesday, September 25, 2019 - 5:05pm | 836Nike Inc (NYSE: NKE) shares are in all-time high territory after the apparel company posted a first-quarter earnings beat Tuesday. Wells Fargo Weighs In Although expectations were very high heading into the first quarter, Nike was able to clear the bar with an earnings report that was solid from...
-
Analyst Reiterates Bullish Stance On Tapestry, Says China Remains Biggest Opportunity
Monday, June 10, 2019 - 1:32pm | 324After hosting an investor dinner with several Tapestry Inc (NYSE: TPR) executives including CEO Victor Luis, Piper Jaffray maintains its bullish stance on the company. The Analyst Piper Jaffray analyst Erinn Murphy reiterated an Overweight rating with a $40 price target. The Thesis Murphy said...
-
Wall Street Weighs In On Qorvo's Impressive Quarter
Wednesday, May 8, 2019 - 12:11pm | 681Qorvo Inc (NASDAQ: QRVO) stock traded higher by 6 percent Wednesday after the company easily beat fiscal fourth-quarter earnings and revenue estimates. Qorvo reported revenue of $681 million, gross margin of 48.2 percent and operating income of $167 million. Qorvo said the fourth quarter was even...
-
Apple As A Service: Analysts Break Down Apple TV+, Apple News+ And Apple Arcade
Tuesday, March 26, 2019 - 11:45am | 1097Apple, Inc. (NASDAQ: AAPL) had one of its most important new service unveilings in recent memory on Monday, giving fans their first glimpse at streaming service Apple TV+, subscription gaming service Apple Arcade and news service Apple News+. Unfortunately for investors, Apple didn't...
-
Best Buy Posts Strong Earnings Just In Time For Black Friday: The Sell-Side Reacts
Wednesday, November 21, 2018 - 1:21pm | 639Retailer Best Buy Co., Inc. (NYSE: BBY) reported better-than-expected third-quarter earnings Tuesday, driven by strong comps, improved services and significant same-store sales increases. The Analysts Piper Jaffray analyst Peter Keith reiterated an Overweight rating on Best Buy and...
-
Analysts Upgrade Nike On $50B Revenue Potential, Direct-To-Consumer Growth
Monday, August 20, 2018 - 2:54pm | 671Nike Inc (NASDAQ: NKE) may be stealing market share back from adidas AG (ADR) (OTC: ADDYY), according to a new report from Susquehanna. Analyst: Nike On Track For $50B In Revenue By 2023 Susquehanna's Sam Poser upgraded Nike from Neutral to Positive and raised the price...
-
Piper Jaffray Raises Funko Price Target, Projects 'Strong Commercial Opportunities'
Thursday, July 19, 2018 - 3:42pm | 527Pop culture collectibles brand Funko Inc (NASDAQ: FNKO)'s brand licensing and more prominent retail placement is positioning the toy company for upside, according to Piper Jaffray. The Analyst Piper Jaffray analyst Erinn Murphy reiterated an Overweight rating on Funko and...
-
Piper Jaffray: Sailpoint Technologies Poised To Benefit From Regulation, Unstructured Data Growth
Wednesday, May 30, 2018 - 5:13pm | 354SailPoint Technologies Holdings Inc (NYSE: SAIL) is well-positioned to benefit from new regulations and the growth of unstructured data, according to an initiation report from PiperJaffray. The Analyst Analyst Andrew Nowinski initiated coverage on Sailpoint Technologies with an Overweight...
-
Piper Jaffray: Wayfair's 'Way Day' Could Land Retailer New Customers
Wednesday, April 18, 2018 - 2:13pm | 355With Wayfair Inc. (NYSE: W)’s new retail holiday Way Day set for April 25, Piper Jaffray analysts see an opportunity for the online retailer to lift revenue and draw new customers. The Analyst Peter Keith of Piper Jaffray reiterated an Overweight rating on Wayfair with a $92 price target...
-
Piper Jaffray Lowers Tempur Sealy Price Target, Says Mattress Firm Gained Market Share With 'Aggressive' Promotions
Monday, March 12, 2018 - 2:25pm | 390Increased competition from Mattress Firm could be weighing on Tempur Sealy International Inc (NYSE: TPX), according to Piper Jaffray. The Analyst Piper Jaffray analyst Peter Keith maintains an Overweight rating on Tempur Sealy but lowered the price target from $75 to $66. The Thesis...
-
Survey: Netflix Subscribers Willing To Pay More
Wednesday, February 21, 2018 - 12:50pm | 405A primary concern for Netflix, Inc. (NASDAQ: NFLX) investors in recent years: whether the company will eventually be able to translate its massive user base and impressive growth numbers into the type of profits that can justify its lofty share price. Netflix has plenty of pricing leverage to ramp...
-
Piper Jaffray Upgrades Supernus Pharmaceutical On Possible Label Expansion For Seizure Drug
Thursday, June 1, 2017 - 3:14pm | 360Positive survey results have helped push Supernus Pharmaceutical Inc (NASDAQ: SUPN) up in Thursday trading and fueled an upgrade from Piper Jaffray. The survey conducted by Piper Jaffray suggests that "a better-tolerated, once-daily sodium channel blocker like Oxtellar XR would be well-...
-
Expecting Negative Earnings For Lumber Liquidators This Week? These Analysts Are
Monday, August 3, 2015 - 10:10am | 522Lumber Liquidators Holdings Inc (NYSE: LL) is scheduled to report its second-quarter results on Wednesday before market open. The Estimize community is expecting the company to earn $0.05 per share on revenue of $257.24 million (based on six estimates) while the Wall Street consensus estimate is...
-
Piper Jaffray On Biogen Downgrade: '6 MG Data Does Not Inspire Confidence…Even More Speculative Than Before'
Wednesday, July 22, 2015 - 11:29am | 478In a report published Wednesday, Piper Jaffray analyst Joshua Schimmer downgraded shares of Biogen Inc (NASDAQ: BIIB) to Neutral from Buy with a price target lowered to $410 from a previous $485 following the company's results for the 6mg Aducanumab arm in its P2 study for Alzheimer's....